Tailored solutions for vaccine development
19 September 2023
In this application note, Eppendorf provides a detailed overview of its tailored automation solutions to streamline vaccine development workflows. Additionally, Eppendorf discusses the evolution of various vaccine technology platforms, from traditional whole pathogen vaccines to more recent recombinant-protein and nucleic-acid vaccines. These newer platforms are recognized for their ability to accelerate development processes and address a wide range of indications rapidly and cost-effectively, meeting the growing demand for new vaccines.